Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Bryan Hubbard

Search

About

Bryan Hubbard is Publisher and co-editor of WDDTY. He is a former Financial Times journalist. He is a Philosophy graduate of London University. Bryan is also the author of several books, including The Untrue Story of You and Secrets of the Drugs Industry.

Archive

2017

2016

2014

2013

2012

2011

2010

2009

2008

2007

2006

Diabetes drug may soon be pulled

May 22nd 2007, 15:39
4,452 views

Avandia (rosiglitazone), the diabetes drug, may soon be pulled from markets around the world after a study discovered it increased the risk of heart attack by 45 per cent. America's drug regulator, the Food and Drug Administration (FDA), has issued an urgent safety alert, and is likely to follow up with a complete ban shortly.

Rosiglitazone is in a new family of drugs known as thiazolidinediones that lower blood glucose levels in people with type II diabetes. Another, Muraglitazar, never made it onto the market after it was also found to increase the risk of heart attacks.

Read more...

1 comment(s)   Add Comment

How doctors choose the 'right' drug for you

May 18th 2007, 13:00
4,603 views

It would be nice to think that he balances and deliberates before making his choice - but there are more dubious pressures at play. All has been revealed by a drug company salesman who has just retired, and perhaps has a pang of conscience.

He writes: "It's my job to figure out what a physician's price is. For some it's dinner at the finest restaurant, for others it's enough convincing data to let them prescribe confidently and for others it's my attention and friendship. But at the most basic level, everything is for sale and everything is an exchange".

Read more...

0 comment(s)   Add Comment

A missed opportunity

May 11th 2007, 12:30
21,765 views

America's senators have missed an enormous opportunity to give their citizens genuine protection against a pharmaceutical industry that is all too rarely brought to account. Instead they voted overwhelmingly in favour of moves that draw the industry and the drug regulator, the , even closer together.

The Senate has voted 93 to 1 in favour of a 'drug safety' measure - S.1082 - which deepens the financial ties between the industry and the FDA. will be doubling the amount of money they pay to the regulator, thus giving strength to the notion that the drug industry is becoming increasingly self-regulating in the USA.

Read more...

0 comment(s)   Add Comment

Sweet enough?

May 8th 2007, 12:08
40,463 views

Drug companies move in a slow, slow way their profits to protect. Even when an argument enters the realm of the blindingly obvious, we continue to see prevarication, the creation of sub-sub committees, review boards, and the review of review boards.

This highly successful strategy has been used on countless occasions to buy time for drugs that are either dangerous or needless.

Read more...

0 comment(s)   Add Comment

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved